Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Duke Energy’s Nuclear Bet Signals the AI Power Shift

Duke Energy filed permit applications to build advanced nuclear reactors in North Carolina, signaling the start of a massive construction boom for the grid.

Actions Speak Louder: Why This CEO Kept Buying His Own Stock

Actions Speak Louder: Why This CEO Kept Buying His Own Stock

CEO William O’Dowd IV has executed over thirty separate stock purchases in 2025 to signal strong confidence in Dolphin Entertainment’s asset strategy.

Find the Next NVIDIA With This Semiconductor ETF

Find the Next NVIDIA With This Semiconductor ETF

AI continues to drive tech gains. For investors searching for the next big semiconductor stock, a thematic ETF that provides broad exposure is a good bet.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

D-Wave vs. IonQ vs. IBM vs. Google: Which Quantum Bets Will Win 2026?

Pure-play quantum companies may be attractive for their massive rallies in recent quarters, but some investors may find legacy tech names are a better fit.

2026 Sector Playbook: 3 Sectors Trading Below Fair Value

If you're concerned about the valuation of AI stock, here are three undervalued sectors in which rotation may unlock value as rates shift lower

The Last Time This Happened, Qualcomm Fell 10%

Qualcomm has just flashed a bearish MACD warning that previously led to a sharp drop. While the long-term story remains intact, bulls need to step in quickly.

From Rust to Riches: 2 Auto Parts Names Built for 2026

A record number of older vehicles on American roads ensures steady demand for aftermarket parts as drivers prioritize repairs over new car payments.

inkl

Read news from The Economist, FT, and more,
with one subscription

Bullseye Bounce: Toms Capital Takes a Stake in Target

Bullseye Bounce: Toms Capital Takes a Stake in Target

The entry of activist investor Toms Capital, coupled with a discounted valuation, signals strong potential for a turnaround for the retailer in the coming year.

Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks

Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks

Institutional insiders are placing big bets on DASH, KVUE, and KYMR. See how much is being spent on these three stocks and which investors are buying.

The Power Bill, the AI Dip, and the Date That Could Flip 2026 Stocks

The Power Bill, the AI Dip, and the Date That Could Flip 2026 Stocks

2026 catalysts to watch: GE Vernova and Bowman Consulting on U.S. grid spending, Constellation on nuclear pricing, plus an AI dip and May 15 rates pivot.

CrowdStrike Is Still Best-in-Breed—But 2026 May Be a Tough Trade

CrowdStrike Is Still Best-in-Breed—But 2026 May Be a Tough Trade

CrowdStrike remains a top cybersecurity stock, but slowing growth and a premium valuation make CRWD a tougher trade heading into 2026

Are These 3 Leading Defensive Stocks Too Crowded Heading Into 2026?

Are These 3 Leading Defensive Stocks Too Crowded Heading Into 2026?

Walmart, Costco, and Procter & Gamble may be too crowded in 2026; see how these defensive stocks may perform if the economy booms, stalls, or stays flat

Reddit Buy Alert: Could It Really Have 40% Upside Potential?

Reddit Buy Alert: Could It Really Have 40% Upside Potential?

Reddit is continuing to attract bullish analyst calls, with some of the more recent updates calling for additional upside of 40% from current levels.

The 3 Stocks That Crushed the S&P 500 in 2025

The 3 Stocks That Crushed the S&P 500 in 2025

SNDK, WDC, and MU dominated performance as shortages in NAND, HDD, and high-bandwidth memory collided with surging demand for AI infrastructure.

Get all your
news in one place.

100’s of premium titles.
One news app.

FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026

Novo Nordisk is down big in 2025, but hope is far from lost in 2026. The company's newly approved weight-loss pill could be the remedy that shares need.

Sleeping With the Enemy: Inside the NVIDIA-Intel Deal

NVIDIA has officially joined forces with Intel to secure essential packaging capacity and stabilize the future of the domestic semiconductor industry.

Rivian's 57% Surge: Head Fake, or Sign of a 2026 Sea-Change?

Shares of Rivian Automotive have kicked into full gear at the end of 2025. However, can the stock sustain its success in 2026 and beyond?

Will the Fed Cut or Pause? These Finance Stocks Can Win Either Way

With rate cuts or a pause on the table, Bank of America, Charles Schwab, and Prudential offer financial exposure built to perform in multiple market scenarios

Get all your
news in one place.

100’s of premium titles.
One news app.

Advanced Micro Devices Is the Most Compelling AI Trade for 2026

Advanced Micro Devices is the most compelling AI trade for 2026 because it is about to start taking market share from NVIDIA.

Microsoft Is Lagging the Market—But Its Moat May Matter More in 2026

Microsoft is trailing the market, but high switching costs and a dominant ecosystem make replacing MSFT more expensive than staying long

The Kroger Catalyst: $2 Billion Reasons to Buy

Smart money is rotating into the grocery sector as aggressive share buybacks and stabilizing inflation make Kroger a top value pick for the coming year.

Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake

With activist investors gone and revenue stabilizing, the undervalued pharmaceutical giant offers a compelling chance for value investors in the coming year.

Gold, Silver, and Copper Are Surging—Here Are 3 Smart Ways to Play It

Investors prepared for a continued precious metals rally might look to these firms for indirect exposure heading into the new year.

What to Expect From Amazon in the 4 Weeks Before Earnings

Amazon is range-bound heading into next month's earnings, but strong AWS optimism and tightening price action point to increasing odds of a pre-earnings rally.

How the Mag 7’s 2025 Laggards Could Turn Into 2026 Winners

This year, investors didn't bet the big returns they expected from the Magnificent Seven. Looking forward, there are reasons to be hopeful.

People

Michael Fiddelke

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

the Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

330,043 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play